摘要
High levels of reactive oxygen species (ROS) are critical for inducing efficient pyroptosis. However, conventional sonosensitizers often exhibit limited ROS generation capacity, thereby restricting their pyroptotic efficacy. Herein, we report a PEGylated Fe/Co co-doped MoS 2 nanozyme (FeCo–MoS 2 ) as an advanced sonosensitizer. The incorporation of Fe and Co dopants optimizes the electronic structure of MoS 2 and increases the density of active sites. Under ultrasound (US) stimulation, FeCo–MoS 2 exhibits multi-enzyme mimetic activities, enabling efficient catalysis of endogenous hydrogen peroxide (H 2 O 2 ) into ROS while simultaneously depleting glutathione (GSH). This dual action disrupts intracellular redox homeostasis within the tumor microenvironment, leading to pronounced mitochondrial oxidative stress. In turn, this activates the caspase-1/GSDMD signaling pathway, culminating in controlled pyroptotic cell death. In vitro, FeCo–MoS 2 combined with US treatment markedly induced cell membrane pore formation and elevated release of IL-18 and lactate dehydrogenase (LDH). In vivo studies demonstrated that this system not only suppressed primary and distant tumor growth and prevented lung metastasis, but also triggered the release of damage-associated molecular patterns (DAMPs). This promoted dendritic cell (DC) maturation and enhanced CD8 + T cell infiltration, thereby eliciting a robust and durable anti-tumor immune response. Collectively, our findings highlight a strategy to potentiate pyroptosis and amplify systemic antitumor immunity, offering new insights into nanozyme-enhanced sonodynamic immunotherapy.
危险品化学品经营许可证(带存储)